TY  - JOUR
AU  - Atallah, Edmond
AU  - Freixo, Cristiana
AU  - Alvarez-Alvarez, Ismael
AU  - Cubero, F. J.
AU  - Gerbes, Alexander L.
AU  - Kullak-Ublick, Gerd A.
AU  - Aithal, Guruprasad P.
PY  - 2021
DO  - 10.1080/17425255.2021.1999410
SN  - 1742-5255
UR  - https://hdl.handle.net/10668/26960
T2  - Expert opinion on drug metabolism & toxicology
AB  - Introduction Idiosyncratic drug-induced liver injury (DILI) is an unpredictable event, and there are no specific biomarkers that can distinguish DILI from alternative explanations or predict its clinical outcomes. Areas covered This systematic review...
LA  - en
PB  - Taylor & francis ltd
KW  - Drug-induced liver injury
KW  - DILI
KW  - hepatotoxicity
KW  - biomarkers
KW  - systematic review
KW  - Serum
KW  - Microrna-122
KW  - Outcomes
KW  - Quality
KW  - Blood
TI  - Biomarkers of idiosyncratic drug-induced liver injury (DILI)-a systematic review
TY  - research article
VL  - 17
ER  -